AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27977439 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral sternal infusion of 0.2% ropivacaine
Number of subjects: 120
Study 26376830 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual pharmacy services plus pharmacist interventions based on shared decision making
Number of subjects: 239
Study 26376830 — intervention group
Group type: COMPARATOR
Intervention: Usual pharmacy services
Number of subjects: 239
Study 24107474 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation (VTV)
Number of subjects: 40
Study 24107474 — intervention group
Group type: COMPARATOR
Intervention: Pressure-limited ventilation (PLV)
Number of subjects: 40
Study 21127013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 10
Study 21127013 — intervention group
Group type: COMPARATOR
Intervention: Nicotine
Number of subjects: 10
Study 19709377 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at points LI‐4 (he gu) and HT‐7 (shen men) immediately after induction of anesthesia
Number of subjects: 60
Study 19709377 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 60
Study 18575355 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific treatment (computer cognitive rehabilitation) consisting of 12 individual sessions of computer exercises
Number of subjects: 11
Study 18575355 — intervention group
Group type: COMPARATOR
Intervention: Control condition (aspecific treatment) consisting of semi-structured interviews with patients
Number of subjects: 11
Study 15154946 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led educational outreach for hyperlipidaemia
Number of subjects: 10303
Study 15154946 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led educational outreach for hypertension
Number of subjects: 10303
Study 15154946 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall specialist nurse-led educational outreach
Number of subjects: 10303
Study 11421962 — intervention group
Group type: EXPERIMENTAL
Intervention: Tier one of the Three Tiered Plan intervention implemented in 1998
Number of subjects: 43
Study 11421962 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-implementation feedback from interns
Number of subjects: 43
Study 11421962 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported knowledge of indigenous health and culture by interns
Number of subjects: 43
Study 11421962 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of the intervention by indigenous hospital liaison officers
Number of subjects: 43
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanillin at 7% v/v
Number of subjects: 16
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanillin at 28% v/v
Number of subjects: 16
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanillin at 56% v/v
Number of subjects: 16
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanillin at 84% v/v
Number of subjects: 16
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing concentrations of vanillin
Number of subjects: 16
Study 9780015 — intervention group
Group type: EXPERIMENTAL
Intervention: OERP latencies
Number of subjects: 16
Study 3183034 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon administered daily for 6 months
Number of subjects: 0
Study 3183034 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 0
Study 3183034 — intervention group
Group type: COMPARATOR
Intervention: Control group (other medical disease - OMD)
Number of subjects: 0
Study 31615466 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential HAIC with cisplatin followed by sorafenib
Number of subjects: 68
Study 31615466 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib alone
Number of subjects: 68
Study 27671836 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hourly feeding
Number of subjects: 150
Study 27671836 — intervention group
Group type: COMPARATOR
Intervention: 3-hourly feeding
Number of subjects: 150
Study 25217501 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 3102
Study 25217501 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 3102
Study 23963102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 0
Study 23963102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day plus Tolterodine 2 mg (twice a day)
Number of subjects: 0
Study 23963102 — intervention group
Group type: COMPARATOR
Intervention: Tolterodine 2 mg (twice a day)
Number of subjects: 0
Study 21412090 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 350
Number of subjects: 100
Study 21412090 — intervention group
Group type: COMPARATOR
Intervention: meglumine sodium diatrizoate
Number of subjects: 100
Study 19170139 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract mouth rinsing (PomElla)
Number of subjects: 32
Study 19170139 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cornstarch in water)
Number of subjects: 32
Study 17022370 — intervention group
Group type: EXPERIMENTAL
Intervention: Glide dental floss
Number of subjects: 120
Study 17022370 — intervention group
Group type: EXPERIMENTAL
Intervention: Butler flossers
Number of subjects: 120
Study 17022370 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM Go‐Betweens cleaners
Number of subjects: 120
Study 17022370 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM Soft‐Picks cleaners
Number of subjects: 120
Study 17022370 — intervention group
Group type: EXPERIMENTAL
Intervention: All products
Number of subjects: 120
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Hokanson system (HEC4)
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtrass 2001 system (F2001)
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop's colored word conflict test
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Postocclusive hyperemia after occlusion times of 5 min
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Postocclusive hyperemia after occlusion times of 8 min
Number of subjects: 10
Study 14752120 — intervention group
Group type: EXPERIMENTAL
Intervention: Postocclusive hyperemia after occlusion times of 13 min
Number of subjects: 10
Study 11097146 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 100 mg twice daily for one week
Number of subjects: 10
Study 11097146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11097146 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 10
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol or Enalapril
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of treatment after 4 years
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (N = 20) with largest initial treatment-induced fall in GFR
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of treatment in Group A
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of treatment in Group B
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment GFR in Group A
Number of subjects: 40
Study 9067912 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment GFR in Group B
Number of subjects: 40
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy butter (B) diet
Number of subjects: 33
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil (SO) diet
Number of subjects: 33
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (OO) diet
Number of subjects: 33
Study 8446039 — intervention group
Group type: COMPARATOR
Intervention: Cocoa butter (CB) diet
Number of subjects: 33
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk chocolate (C) diet
Number of subjects: 33
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa butter + dairy butter (CB+B) diet (4:1, MIX)
Number of subjects: 33
Study 8446039 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma very-low density lipoprotein (VLDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and apo A-I levels
Number of subjects: 33
Study 3716914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking and caffeine administration during task performance
Number of subjects: 9
Study 3716914 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine administration
Number of subjects: 9
Study 3716914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 9
Study 3716914 — intervention group
Group type: EXPERIMENTAL
Intervention: Task performance
Number of subjects: 9
Study 29699979 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted retinal photocoagulation (TRP)
Number of subjects: 24
Study 27321608 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision-based speed-of-processing (VSOP) training
Number of subjects: 21
Study 27321608 — intervention group
Group type: COMPARATOR
Intervention: Mental leisure activities (MLA)
Number of subjects: 21
Study 24720741 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 1600 µl
Number of subjects: 82
Study 24720741 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 1200 µl
Number of subjects: 82
Study 24720741 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh injections
Number of subjects: 82
Study 22555227 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 50
Study 22555227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19699488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone (40-160mg/d)
Number of subjects: 398
Study 19699488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 398
Study 18605811 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 173
Study 18605811 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 173
Study 15620501 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicryl Rapide
Number of subjects: 60
Study 15620501 — intervention group
Group type: COMPARATOR
Intervention: Vicryl
Number of subjects: 60
Study 11836328 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose testosterone (200 mg) in older men
Number of subjects: 68
Study 11836328 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose testosterone (100 mg) in young men
Number of subjects: 68
Study 11836328 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) in older men
Number of subjects: 68
Study 10392872 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture-mediated closure device
Number of subjects: 600
Study 10392872 — intervention group
Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 600
Study 8907566 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-interferon treatment
Number of subjects: 347
Study 8907566 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 347
Study 8907566 — intervention group
Group type: COMPARATOR
Intervention: Control (non-responders)
Number of subjects: 347
Study 1919966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation preoperative treatment
Number of subjects: 0
Study 1919966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation
Number of subjects: 0
Study 7128838 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (800 mg daily for the first 2 months, 600 mg daily for the next 2 months, and 400 mg daily for the final 2 months)
Number of subjects: 65
Study 7128838 — intervention group
Group type: COMPARATOR
Intervention: No treatment for 6 months
Number of subjects: 65
Study 31883123 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimand framework
Number of subjects: 0
Study 31883123 — intervention group
Group type: COMPARATOR
Intervention: Traditional intention-to-treat or per protocol analysis
Number of subjects: 0
Study 30966821 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional risk assessment (arm A)
Number of subjects: 43447
Study 30966821 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery calcification (arm B)
Number of subjects: 43447
Study 30966821 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 43447
Study 28455814 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training at 80% of 1‐repetition maximum (1‐RM) for 3 weeks
Number of subjects: 20
Study 25493927 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 46
Study 25493927 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (group C)
Number of subjects: 46
Study 23684375 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia based health information
Number of subjects: 101
Study 23684375 — intervention group
Group type: COMPARATOR
Intervention: Verbal health information
Number of subjects: 101
Study 21461323 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic internet-based intervention alone
Number of subjects: 264
Study 21461323 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic internet-based intervention with prescribed bedtime routine
Number of subjects: 264
Study 21461323 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual routine)
Number of subjects: 264
Study 18339412 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused instruction during a 4‐h training session
Number of subjects: 40
Study 18339412 — intervention group
Group type: COMPARATOR
Intervention: Standard written instructions in PIM application
Number of subjects: 40
Study 16433714 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional-directed implementation programme
Number of subjects: 13
Study 16433714 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centred implementation programme
Number of subjects: 13
Study 16433714 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual hospital outpatient care)
Number of subjects: 13
Study 12036483 — intervention group
Group type: EXPERIMENTAL
Intervention: ART plus CTX
Number of subjects: 10
Study 12036483 — intervention group
Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 10
Study 10213347 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride (1.162 mg)
Number of subjects: 45
Study 10213347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10213347 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.54 mg)
Number of subjects: 45
Study 7840072 — intervention group
Group type: EXPERIMENTAL
Intervention: Boron supplementation
Number of subjects: 0
Study 2400038 — intervention group
Group type: EXPERIMENTAL
Intervention: Admissions attended by physicians licensed for more than 15 years
Number of subjects: 0
Study 2400038 — intervention group
Group type: COMPARATOR
Intervention: Admissions attended by younger physicians
Number of subjects: 0
Study 2400038 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 0
Study 2400038 — intervention group
Group type: COMPARATOR
Intervention: Male patients
Number of subjects: 0
Study 14317 — intervention group
Group type: EXPERIMENTAL
Intervention: FC 35aA
Number of subjects: 30
Study 14317 — intervention group
Group type: COMPARATOR
Intervention: Dipotassic chlorazepate, paracetamol and codeine (individual components)
Number of subjects: 30
Study 6948502 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 81
Study 6948502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 31305927 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy turnover (ET)
Number of subjects: 16
Study 31305927 — intervention group
Group type: COMPARATOR
Intervention: Low energy turnover (ET)
Number of subjects: 16
Study 29510857 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow flexed (EF) crutch setup
Number of subjects: 30
Study 29510857 — intervention group
Group type: COMPARATOR
Intervention: Elbow extended (EE) crutch setup
Number of subjects: 30
Study 27366548 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture applied to the P6 acupuncture point for 20 min during surgery
Number of subjects: 70
Study 27366548 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 70
Study 24453483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise intervention including strength and balance training and 8-form Tai Chi Chuan
Number of subjects: 56
Study 24453483 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 22405506 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-level unemployment
Number of subjects: 379
Study 22405506 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher income
Number of subjects: 379
Study 22405506 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood unemployment
Number of subjects: 379
Study 22405506 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood poverty
Number of subjects: 379
Study 22405506 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood education
Number of subjects: 379
Study 19920815 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET with SUV threshold of 2.0
Number of subjects: 99
Study 19920815 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET with SUV threshold of 1.5
Number of subjects: 99
Study 19920815 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 99
Study 19920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 99
Study 19920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 99
Study 19920815 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging modalities
Number of subjects: 99
Study 17350342 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of antiepileptic drugs (AEDs)
Number of subjects: 115
Study 17350342 — intervention group
Group type: COMPARATOR
Intervention: Continued treatment with AEDs
Number of subjects: 115
Study 15709822 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 48
Study 15709822 — intervention group
Group type: COMPARATOR
Intervention: Negative mood induction
Number of subjects: 48
Study 12358962 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal anti-emetic prophylaxis including total intravenous anaesthesia with propofol, high fractional inspired oxygen (80%), omission of nitrous oxide, dexamethasone 8 mg, haloperidol 10 microg.kg(‐1), and tropisetron 2 mg.
Number of subjects: 108
Study 12358962 — intervention group
Group type: COMPARATOR
Intervention: Balanced propofol-desflurane anaesthesia without prophylactic anti-emetics (Control group).
Number of subjects: 108
Study 12358962 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal anti-emetic prophylaxis
Number of subjects: 108
Study 9972743 — intervention group
Group type: EXPERIMENTAL
Intervention: Delacroix-Chevalier retractor
Number of subjects: 60
Study 9972743 — intervention group
Group type: COMPARATOR
Intervention: Pittman retractor
Number of subjects: 60
Study 9972743 — intervention group
Group type: COMPARATOR
Intervention: Rultract retractor
Number of subjects: 60
Study 7579054 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human atrial natriuretic peptide (ANP) 0.01 microgram/kg per minute
Number of subjects: 20
Study 7579054 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study 2148912 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms human atrial natriuretic factor-(99-126) (hANF)
Number of subjects: 8
Study 2148912 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 8
Study 535145 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy and/or chemotherapy
Number of subjects: 100
Study 535145 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 535145 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial determinations post-treatment
Number of subjects: 100
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐etch/bulk‐fill in syringe
Number of subjects: 295
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐etch/bulk‐fill in capsules
Number of subjects: 295
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐etch/incremental
Number of subjects: 295
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: selective enamel‐etching/bulk‐fill in syringe
Number of subjects: 295
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: selective enamel‐etching/bulk‐fill in capsules
Number of subjects: 295
Study 31531552 — intervention group
Group type: EXPERIMENTAL
Intervention: selective enamel‐etching/incremental
Number of subjects: 295
Study 31531552 — intervention group
Group type: COMPARATOR
Intervention: bulk‐fill composite (capsules or syringes)
Number of subjects: 295
Study 28448417 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-gated prospective-triggered multidetector row computed tomography angiography with IMR (group C)
Number of subjects: 31
Study 28448417 — intervention group
Group type: COMPARATOR
Intervention: iDose reconstruction (group B)
Number of subjects: 31
Study 28448417 — intervention group
Group type: COMPARATOR
Intervention: Filtered back-projection reconstruction (group A)
Number of subjects: 31
Study 26099544 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary psychotherapeutic intervention (4 to 6 sessions with consultations)
Number of subjects: 23
Study 26099544 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 23
Study 25048310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose prednisolone (4 mg/kg/day)
Number of subjects: 63
Study 25048310 — intervention group
Group type: COMPARATOR
Intervention: Usual-dose prednisolone (2 mg/kg/day)
Number of subjects: 63
Study 22351891 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin (post-CPG)
Number of subjects: 1033
Study 22351891 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (post-CPG)
Number of subjects: 1033